
Maria Glymour, SD
Chair and Professor, Epidemiology - Boston University School of Public Health
Biography
Research Interests
- Alzheimer's disease and related causes of cognitive aging and dementia
- Social determinants of health and health equity
- Social policies and health
- Causal inference in social epidemiology and dementia research
My research focuses on how social factors experienced across the lifecourse, from infancy to adulthood, influence cognitive function, dementia, stroke, and other health outcomes in old age. I am especially interested in education and other exposures amenable to policy interventions. The health of current cohorts of elderly individuals in the US reflect a lifetime of social exposures, including educational experiences shaped by major changes in schooling policies. Education is especially interesting because it is such a powerful predictor of health and historically, access to education has frequently been restricted based on race, gender, and other socially enforced criteria. One thread of my research examines how changes in schooling laws and school quality in the 20th century might have influenced the health and cognitive outcomes of current cohorts of elderly, including adults subject to race-based school segregation. Our results suggest that extra schooling has substantial benefits for memory function in the elderly. I have also worked on the influence of "place" on health, for example to understand the excess stroke burden for individuals who grew up in the US Stroke Belt. In a project with colleagues including Drs. Rachel Whitmer, Elizabeth Rose Mayeda, and Paola Gilsanz, we are continuing a unique multi-ethnic cohort of older adults in Northern California, with a wealth of lifecourse biological and social data to offer insight into the reasons for racial/ethnic differences in Alzheimer's and dementia risk (https://rachelwhitmer.ucdavis.edu/khandle).
A separate theme of my research focuses on overcoming methodological problems encountered in analyses of social determinants of health, Alzheimer's disease, and dementia. For many reasons, research focusing on lifecourse epidemiology as well as cognitive aging introduces substantial methodological challenges. Sometimes, these are conceptual challenges, and clear causal thinking can help! Many of these challenges are being addressed in the MELODEM (MEthods in LOngitudinal research on DEMentia) initiative, an international group of researchers focusing on analytic challenges in research on dementia and cognitive aging. MELODEM has working group phone calls on the first and third Thursdays of the month, open to all (https://sites.bu.edu/melodem/). My group works with numerous colleagues on methods to improve measurement, including crosswalking across data sets. For example, in work with Dr. Zeki Al Hazzouri, we are linking data sets with detailed information at different lifecourse periods -- e.g., childhood, early adulthood, and later adulthood -- to better evaluate long-term effects of exposures at specific sensitive ages. In work with Dr. Cathy Schaefer, Ron Krauss, and many others, we are fielding emulated trial designs in the large, diverse Kaiser Permanente Northern California cohort. This setting is exceptional for emulated trial designs because of the large size, long follow-up, and combination of high-quality clinical data plus social and genetic information for large groups of study participants.
I have advocated the use of causal directed acyclic graphs (DAGs) as a standard research tool to represent our causal hypotheses and help elucidate potential biases in proposed analyses. In other cases, the methodological problems require more analytical solutions that have been developed elsewhere in epidemiology or in other disciplines, but are rarely applied to these research questions. Instrumental variables analyses of natural or induced experiments are one promising example. Genetic variations have recently been advanced as possible instrumental variables to estimate the health effects of a wide range of phenotypes, an approach sometimes called “Mendelian Randomization.” Using genetic polymorphisms as instrumental variables could provide a very powerful tool for social epidemiology, but the inferences from such analyses rest on strong assumptions. Thus I am currently working with a team to explore approaches to evaluating the plausibility of those assumptions in applications for social epidemiology.
Students and post-doctoral fellows interested in research collaborations related to my work are welcome to send me an email directly or contact Robin Hyatt, rshyatt@bu.edu, who handles my calendar.
Education
- Harvard School of Public Health, SD Field of Study: Epidemiology
- University of Chicago, AB Field of Study: Biology
- Harvard School of Public Health, SM/ScM Field of Study: Epidemiology
Websites
Classes Taught
- SPHEP912
Publications
- Published on 3/4/2025
Sims KD, Glymour MM, Ncube CN, Willis MD. Invited commentary: improving spatial exposure data for everyone-life-course social context and ascertaining residential history. Am J Epidemiol. 2025 Mar 04; 194(3):573-577. PMID: 39098825.
Read At: PubMed
- Published on 3/4/2025
Kim MH, Frøslev T, White JS, Glymour MM, Ilango SD, Sørensen HT, Pedersen L, Hamad R. Kim et al respond to "Dispersal policies, neighborhood disadvantage, and refugee health in a Nordic context". Am J Epidemiol. 2025 Mar 04; 194(3):649-650. PMID: 39086093.
Read At: PubMed
- Published on 3/4/2025
Kim MH, Frøslev T, White JS, Glymour MM, Ilango SD, Sørensen HT, Pedersen L, Hamad R. Mediating pathways between neighborhood disadvantage and cardiovascular risk: quasi-experimental evidence from a Danish refugee dispersal policy. Am J Epidemiol. 2025 Mar 04; 194(3):635-644. PMID: 38932569.
Read At: PubMed
- Published on 2/20/2025
Li DK, Cheng D, Parks A, Rieu-Werden ML, Polekhina G, Mahady SE, Glymour MM, Chan AT, Shah SJ. Functional disability after clinically significant extracranial bleeding: a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) Trial. J Thromb Haemost. 2025 Feb 20. PMID: 39986609.
Read At: PubMed
- Published on 2/1/2025
Ackley SF, Wang J, Chen R, Hill-Jarrett TG, Rojas-Saunero LP, Stokes A, Shah SJ, Glymour MM. Methods to crosswalk between cognitive test scores using data from the Alzheimer's Disease Neuroimaging Cohort. Alzheimers Dement. 2025 Feb; 21(2):e14597. PMID: 40000573.
Read At: PubMed
- Published on 2/1/2025
Ferguson EL, Zimmerman SC, Jiang C, Choi M, Meyers TJ, Hoffmann TJ, Gilsanz P, Oni-Orisan A, Wang J, Whitmer RA, Risch N, Krauss RM, Schaefer CA, Glymour MM. Independent associations of high-density lipoprotein cholesterol and triglyceride levels with Alzheimer's disease and related dementias. Alzheimers Dement. 2025 Feb; 21(2):e14575. PMID: 40008914.
Read At: PubMed
- Published on 2/1/2025
Kezios KL, Colvin CL, Grasset L, Duarte CD, Glymour MM, Zeki Al Hazzouri A. 20-Year income volatility and cognitive function in the National Longitudinal Survey of Youth (1979) cohort: A replication and extension of CARDIA findings. Soc Sci Med. 2025 Mar; 368:117798. PMID: 39929027.
Read At: PubMed
- Published on 1/28/2025
Kim MH, Miramontes S, Mehta S, Schwartz GL, Kim YJ, Yang Y, Hill-Jarrett TG, Cevallos N, Chen R, Glymour MM, Ferguson EL, Zimmerman SC, Choi M, Sims KD. Extracting Housing and Food Insecurity Information From Clinical Notes Using cTAKES. Health Serv Res. 2025 Jan 28; e14440. PMID: 39871689.
Read At: PubMed
- Published on 1/27/2025
Meza E, Romero KRF, Allen IE, González HM, Glymour MM, Torres JM. Offspring education and cognitive health: A comparison between Hispanic and White older adults in the United States. Alzheimers Dement. 2025 Feb; 21(2):e14523. PMID: 39868479.
Read At: PubMed
- Published on 1/10/2025
Wu Y, Hayes-Larson E, Zhou Y, Bouteloup V, Zimmerman SC, Pederson AM, Planche V, Seamans MJ, Westreich D, Glymour MM, Gibbons LE, Dufouil C, Mayeda ER. Statistical harmonization of versions of measures across studies using external data: Self-rated health and self-rated memory. Ann Epidemiol. 2025 Feb; 102:86-90. PMID: 39800088.
Read At: PubMed
View 488 more publications:View Full Profile at BUMC
News & In the Media
- Published on February 15, 2025
- Published on January 9, 2025
- Published on December 13, 2024
-
Published on December 7, 2024
A Caregiving Chasm: Professor Reflects on the Shortcomings of the US Healthcare System
-
Published on November 13, 2024
Public Health Master’s Degrees in Epidemiology: What Questions to Ask
- Published on October 11, 2024
-
Published on October 8, 2024
Innovative Approaches to Prevent Dementia Funded by $28.8 Million Federal Grant
-
Published on September 27, 2024
Professor Receives $29M NIH Grant to Study Dementia Risk Factors, Prevention, and Treatment
-
Published on April 12, 2024
Depression May Lead to Faster Cognitive Decline among Black, Latino Adults
- Published on November 9, 2023
-
Published on October 6, 2023
Both High and Low HDL Cholesterol Tied to Increased Risk of Dementia
- Published on October 5, 2023
-
Published on September 8, 2023
After 2020 Increase, Excess Mortality among People with Dementia Drops in Year 2 of COVID
- Published on August 31, 2023
-
Published on July 10, 2023
FDA Gives Full Approval for New Alzheimer’s Drug, but Will It Help Black Patients?
-
Published on July 7, 2023
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
-
Published on July 6, 2023
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients